AZ admitted that the vaccine developed with the University of Oxford to protect against COVID-19 may cause Thrombosis with ...

Experts stressed that recent disclosure by drugs multinational AstraZeneca in a London court that the Covishield vaccine can cause blood clots in “very rare cases” is not something that was previously ...

Prime Minister Narendra Modi flagged off India’s mass Covid-19 vaccination drive on Saturday with two vaccines - Serum Institute of India’s (SII) Covishield and Bharat Biotech’s homegrown vaccine ...

NEW DELHI, (IANS) – Thrombosis Thrombocytopenia Syndrome (TTS) — a blood clot disorder — is a rare side effect of AstraZeneca’s Covid vaccine, and the benefits far outweigh the risks of the jab, said ...

File image: A ground staff walks past a container kept at the Cargo Terminal 2 of Delhi's Indira Gandhi International Airport, which according to the officials will be used as a COVID-19 vaccine ...

Add Yahoo as a preferred source to see more of our stories on Google. Covishield was developed by the British-Swedish company in collaboration with Oxford University, UK, and produced by the Serum ...

Nepal took delivery of one million doses of Covishield vaccine ordered from the Serum Institute of India, on Sunday. Photo: AMIT MACHAMASI Amidst the pandemic, Covid-19 vaccines have become a means ...

Read Covid-19 Vaccine latest news on The Economic Times. When will Covid-19 Vaccine be available in India? Covid-19 Vaccine ...

Read Coronavirus vaccine latest news on The Economic Times. When will coronavirus vaccine be available in India? Coronavirus ...

The Centre so far has used nearly 73 per cent of the total budget allocated for COVID-19 vaccination in the current fiscal, majority of which has gone to Pune-based Serum Institute of India (SII), ...